Epidemiological evidence supports the notion that healthy dietary approaches can reduce cardiovascular morbidity. The Dietary Approaches to Stop Hypertension (DASH) trial demonstrated that the combination of increased fruit, vegetable, and fish consumption with reductions in saturated fat intake reduced blood pressure in hypertensive patients. 1 Likewise, the Lyon Diet Heart Study showed that dietary intervention comprised of increased consumption of fruit, vegetables, fish, as well as the omega-3 fatty acid, α-linolenic acid, reduced cardiovascular morbidity and prolonged survival following myocardial infarction. 2 There is also extensive evidence derived from epidemiological studies suggesting that the polyphenol compounds commonly found in grapes, such as flavonoids, phenolic acids, and resveratrol, reduce cardiovascular mortality. 3 McCall et al. reported that increased fruit and vegetable consumption dose-dependently improved micro-vascular function. 4 Unfortunately, this report did not specifically document which fruits and/or vegetables were consumed. Grapederived foods such as red wine and grape juice can alleviate hypertension in rats and humans, 5-8 but the underlying mechanisms remain poorly understand. Here, we investigated the effects of grape consumption in the context of hypertension.
Epidemiological evidence supports the notion that healthy dietary approaches can reduce cardiovascular morbidity. The Dietary Approaches to Stop Hypertension (DASH) trial demonstrated that the combination of increased fruit, vegetable, and fish consumption with reductions in saturated fat intake reduced blood pressure in hypertensive patients. 1 Likewise, the Lyon Diet Heart Study showed that dietary intervention comprised of increased consumption of fruit, vegetables, fish, as well as the omega-3 fatty acid, α-linolenic acid, reduced cardiovascular morbidity and prolonged survival following myocardial infarction. 2 There is also extensive evidence derived from epidemiological studies suggesting that the polyphenol compounds commonly found in grapes, such as flavonoids, phenolic acids, and resveratrol, reduce cardiovascular mortality. 3 McCall et al. reported that increased fruit and vegetable consumption dose-dependently improved micro-vascular function. 4 Unfortunately, this report did not specifically document which fruits and/or vegetables were consumed. Grapederived foods such as red wine and grape juice can alleviate hypertension in rats and humans, [5] [6] [7] [8] but the underlying mechanisms remain poorly understand. Here, we investigated the effects of grape consumption in the context of hypertension.
Abnormalities of resistance arteries play a role in the pathogenesis and maintenance of hypertension. Because increased peripheral resistance is influenced exponentially to the fourth power by a narrowed lumen diameter, mechanisms that reduce lumen size such as alterations of vascular structure, stiffness, and function are important. Structural abnormalities are comprised of reduced lumen diameter and thickening of the vascular media, resulting in an increased media-lumen ratio. Stiffening of an artery also passively reduces lumen diameter. Third, impaired vasodilatory function, which occurs in hypertensive patients, 9 leads to functional reduction in lumen diameter. Given the importance of resistance arteries, and based on our previous finding that resveratrol, a polyphenolic the first two authors contributed equally to this work. 1 
Background
We previously reported that resveratrol, a polyphenol found in red grapes, attenuated changes in small artery geometry and stiffness, as well as cardiac hypertrophy and cardiac function in the spontaneously hypertensive rat (SHr). However, in addition to resveratrol, grapes contain a variety of bioactive polyphenols such as catechins, anthocyanins, and flavonoids. therefore, we investigated the effects of grape consumption in SHr.
Methods
Wistar-Kyoto (WKY) rats and SHr were treated with freeze-dried grape powder for 10 weeks. Dilatory, geometry, and stiffness properties of mesenteric small arteries were assessed by pressurized myography. Left ventricular mass index and cardiac function were assessed by two-dimensional guided M-mode and pulse-wave Doppler echocardiography. results elevated blood pressure in SHr was associated with remodeling and impaired endothelium-dependent relaxation of small arteries. Augmented left ventricular mass index (reflecting hypertrophy) and diminished cardiac function were also evident in SHr. Although grape treatment failed to affect cardiac dysfunction, it elicited a significant reduction in blood pressure, improved arterial relaxation, increased vascular compliance, and attenuated cardiac hypertrophy.
conclusions treatment with whole grape powder conferred mild vascular and cardiac benefits in SHr. therefore, dietary grape consumption may be a feasible and salutary adjunct to pharmacological treatment of human hypertension.
original contributions
Effect of Grape Consumption on SHR compound found in grapes modulates resistance artery remodeling, 10 we queried whether grape consumption might improve blood pressure by correcting aberrations of the resistance microvasculature.
Methods
See Supplementary Methods online for expanded methods and Supplementary Data.
Animals. This study was conducted according to recommendations from the Animal Care Committee of the University of Manitoba and the Canadian Council of Animal Care. Eightweek old male spontaneously hypertensive rat (SHR) and Wistar-Kyoto (WKY) rats were obtained from Charles River (Senneville, Quebec, Canada), housed under a 12-h light/dark cycle at 22 °C and 60% humidity, and fed ad libitum. After 7 days to acclimatize, rats were trained for blood pressure measurement using a tail plethysmography apparatus (CODA NonInvasive Blood Pressure System; Kent Scientific, Torrington, CT). Vehicle or freeze-dried table grape powder (600 mg/day by gavage; California Table Grape Commission (CTGC)) was administered from 10 to 20 weeks of age. This dose was calculated based on the ability of 3.0% wt/wt dietary table grape powder to improve salt-sensitive hypertension in the Dahl salt-sensitive rat. 11 Grape powder phytochemical content is described in Table 1 .
Cardiac measurements. Cardiac hypertrophy was assessed as heart weight:body weight and left ventricular index (left ventricular mass:body weight). Two-dimensional guided M-mode echocardiography and pulse-wave Doppler echocardiography were used to assess systolic and diastolic function, respectively. Systolic function was measured as left ventricular ejection fraction and cardiac output. Diastolic function was assessed by measuring the isovolumic relaxation time.
Small arteries. Vascular function, mechanics, and geometry were evaluated as described in Supplementary Methods online.
Statistics. Results are presented as means ± s.e.m. Data were analyzed by analysis of variance or two-way analysis of variance for repeated measures, followed respectively by StudentNewman-Keuls or Bonferroni post-tests to detect betweengroup differences. P < 0.05 was considered significant.
results

Blood pressure
SHR exhibited elevations in blood pressure ( Table 2 ; P < 0.01) that were attenuated by grape treatment.
Vascular function
Mesenteric small arteries from untreated SHR exhibited impaired endothelium-dependent relaxation, as evidenced by an elevated EC50 of acetylcholine ((2 × 10 -7 mol/l); Figure 1 ; P < 0.05). In contrast, arteries from grape-treated SHR dilated significantly better ((EC50: 2 × 10 -9 mol/l); P < 0.01) in response to acetylcholine such that the EC50 of acetylcholine was comparable to that for arteries from WKY rats (untreated (5 × 10 -9 mol/l) or grape-treated (2 × 10 -9 mol/l)). There were no differences in endothelium-independent relaxation in response to sodium nitroprusside between WKY and SHR, either in the presence or absence of grape powder treatment (data not shown).
Vascular geometry
Narrower lumen diameters (P < 0.01) and thicker media widths (P < 0.05) resulted in greater media/lumen ratios ( Table 2 ; P < 0.01) and reduced isobaric stress (Figure 2a ; P < 0.01) in SHR vessels. Media cross-sectional areas and external diameters did not differ significantly between strains. Grape treatment partially attenuated media thickening, resulting in a significant decrease in external diameter ( Table 2 ; P < 0.01) and normalization of isobaric stress (Figure 2a ) in grapetreated SHR vessels.
Vascular compliance
The rightward shift (P < 0.05) of the stress-strain curve in arteries from grape-treated SHR vs. untreated SHR reflects an increase in compliance (Figure 2b ). Grape treatment also appeared to initiate an increase in compliance of WKY arteries, although the shift did not reach statistical significance.
Vascular compliance is influenced by the fact that transduction of intraluminal pressure to the vessel wall as stress is modulated by (i) the geometry of the artery and (ii) wall component stiffness. Information regarding solely the stiffness of wall components such as elastin, collagen, and smooth muscle cells is provided when elastic modulus is plotted against stress, as geometry is mathematically eliminated as a contributor to Normalized heart weight and left ventricular mass were significantly greater in SHR, indicating the presence of cardiac hypertrophy (Figure 3 ; P < 0.01); grape treatment partially attenuated both parameters. As shown in Figure 4 , systolic function was impaired in SHR, as fractional shortening, ejection fraction, and cardiac output were significantly reduced.
Isovolumic relaxation, an indicator of diastolic function, was also impaired. Neither systolic nor diastolic function was affected by grape treatment.
discussion
Though an anti-hypertensive effect of dietary grape product consumption has been reported, 5-8 , 11 little is known about the mechanism(s) involved. To our knowledge, this is the first report that, in SHR, the ability of a freeze-dried table 
original contributions
Effect of Grape Consumption on SHR grape powder to reduce blood pressure was associated with improved endothelium-dependent relaxation and compliance of small arteries. Improvement of endothelial function has previously been reported in non-hypertensive populations as an effect of grape-derived products. For example, grape juice consumption improved flow-mediated dilation in patients with metabolic syndrome 12 and coronary artery disease. 13 A total grape product also improved basal flow-mediated dilation and attenuated high-fat induced endothelial dysfunction in healthy individuals. 14 Finally, in patients with coronary heart disease, a polyphenol extract from red grapes improved endothelial function. 15 Extracts from grape seed do not consistently improve endothelial function in healthy individuals 16 nor in patients with cardiovascular disease, 17 but have been shown to cause relaxation when directly applied to aortic rings 18 or to improve acetylcholine-induced relaxation in the streptozotocin-induced rat model of diabetes. 19 We add to these reports that grape treatment, in the context of hypertension, may lower blood pressure in part by improving vasodilatory function. Vascular compliance is the ability of a vessel to buffer changes in pressure. We observed an increase in compliance of small arteries from grape-treated SHR as depicted by a rightward shift of the stress-strain curve. This response to grape treatment confers at least two benefits. First, in the presence of residually-elevated blood pressure, the ability of grape treatment to increase compliance, and therefore pressurebuffering capacity, may protect the arterial wall from pressure-induced damage. Second, the increased compliance may diminish resistance to blood flow, thereby contributing to the antihypertensive effect of grape treatment.
Vascular compliance is determined by passive geometry as well as intrinsic stiffness of arterial wall components. Thus, the effects of grape on these parameters were considered. Despite the increased compliance in grape-treated SHR vessels, the stiffness of wall components (i.e., connective tissue, elastin, and collagen fibers, smooth muscle cells, and endothelial cells; depicted by elastic modulus vs. stress plot) was comparable between WKY and SHR arteries; grape treatment tended to reduce wall component stiffness of arteries from either strain, albeit not significant statistically. This tendency might explain the slight rightward shift of the stress-strain curve (i.e., increased compliance?) of grape-treated WKY arteries. Nonetheless, while perhaps a minor contributor, changes in wall component stiffness do not account for the ability of grape powder to increase vascular compliance.
The most likely alternative is that the grape powder affected the geometry of SHR arteries. In hypertension, eutrophic, and hypertrophic remodeling modulate vascular geometry. In eutrophic remodeling, vascular wall material appears rearranged around a narrowed lumen without evidence of net growth. In hypertrophic remodeling, the media cross-sectional area increases to encroach on the lumen, indicating the presence of growth. Compared to WKY, remodeling and growth indices were 93 and 7%, respectively, in untreated SHR vessels. This indicates that the changes in geometry probably involved a combination of remodeling and hypertrophic growth, with predominance of the former. Indeed, vessels from untreated SHR exhibited typical hallmarks of eutrophic remodeling, including reduced lumen diameter, increased media width, and augmented media-to-lumen ratio. Grape treatment increased the remodeling index further to 144% and reduced growth index to -22%, suggesting that the grape effects largely involved intensification of eutrophic remodeling-that is, without further reduction in lumen diameter, grape treatment reduced external diameter by attenuating media thickening. Changes of these parameters in these directions are important modulators of vascular response to stress, and are consistent with our finding that grape treatment increased compliance of SHR arteries.
In the heart, the ability of grape treatment to improve indicators of hypertrophy may be, at least in part, attributable to resveratrol content. Indeed, we previously reported that a dose of 3 mg/kg/day (~0.6 mg/day in a 250 g rat) of resveratrol suppressed the development of left ventricular wall thickening in SHR without reducing blood pressure, and this was associated with a reduction in oxidative stress. 20 Here, as a constituent of the grape powder, a much lower calculated dose of 0.001 mg/ day of resveratrol was administered. Therefore, it is likely that the effects of grape treatment on hypertrophy might be due to other grape constituents, or even to an indirect response to grape-induced lowering of blood pressure. Notably, resveratrol 
Effect of Grape Consumption on SHR also improved systolic and diastolic function whereas grape powder did not, suggesting that therapeutic as opposed to naturally occurring doses of constituents such as resveratrol might be required to affect cardiac function. Alternatively, an experimental design in which duration of grape treatment was prolonged beyond 10 weeks might have revealed effects of grape treatment on cardiac dysfunction.
Interestingly, the arterial effects of whole grape powder also differ from those that we previously reported for resveratrol in SHR. Resveratrol failed to reduce blood pressure, yet attenuated lumen narrowing, and increased vascular compliance. 10 In contrast, grape powder caused significant blood pressurelowering, reduced compliance, but had no effect on lumen diameter. These differences reinforce the notion that while resveratrol may slightly contribute to the beneficial effects of grape treatment in SHR, it is clearly not the only grape constituent involved.
There are a number of reports documenting effects of fruitderived treatments in experimental models of cardiovascular disease. In particular, cardioprotective effects of foods that contain shared bioactive constituents (CTGC, refs. 21, 22 ) such as catechins, anthocyanins, flavonols, and stilbenes (e.g., resveratrol) have been reported. For example, in SHR, a blueberry-enriched diet delayed the progression of hypertension, reduced renal vascular resistance, and was associated with an improvement in renal redox status. 23 Dietary blueberry consumption also exerts direct effects on the heart; in the absence of blood pressure lowering, a blueberry-enriched diet limited infarct expansion, normalized posterior ventricular wall thickness, and improved survival following coronary ligation in rat. 22 Cranberry juice effects may be similar, since acute treatment reduced blood pressure in anesthetized rats, and extraluminal exposure of aortic rings to cranberry juice caused L-NAME-sensitive vasodilation. 24 An important consideration is that extraction protocols that differentially isolate and/or concentrate specific bioactive constituents might translate into disparate pharmacological effects. For example, Al-Awwadi et al. 25 showed in the fructose-fed rat that hypertension, cardiac hypertrophy, and overproduction of reactive oxygen species could be attenuated by either an anthocyanin-rich grape skin polyphenolic extract or a tannin-rich grape seed extract, whereas a procyanadin-rich grape seed extract failed to significantly improve blood pressure or cardiac structure. Thus, it bears reiterating that in the current study, we delivered a freeze-dried grape powder (not an extract) made from a composite of red, green, and blue-black California grapes.
The grape powder dose of 600 mg/day was selected based on the justification presented by Seymour et al when reporting grape effects in a salt-sensitive hypertensive rat model. 11 Briefly, given (i) the assumption that one human serving of fresh grapes is ¾ cup (~126 g), (ii) the fact that 126 g fresh grapes corresponds to ~23 g of grape powder (per the CTGC), and (iii) the DASH diet trials prescribe nine servings of fruit/ vegetables per day, 1 the rat body-weight based bioequivalent dose is 600 mg/day. However, the routes of administration differ in that Seymour et al. 11 used a 3% diet to ~600 mg/day, whereas here, a bolus dose was delivered by once-daily oral gavage. The advantage of incorporating the grape powder into the diet is that it better models the 9 servings/day of fruit/ vegetables suggested by the DASH diet trials; 1 in contrast, oral gavage ensures consistent delivery of the dose, albeit all at once. It is certainly possible that the pharmacokinetic and 
Effect of Grape Consumption on SHR pharmacodynamic profiles of the grape powder (and bioactive metabolites?) might differ between the two oral dosing paradigms as previously shown for lovastatin 26 and sulindac 27 vis-à-vis different areas under the concentration-time curve. In contrast, the pharmacokinetics and pharmacodynamics may be independent of the method of administration, as demonstrated for aspirin-derived salicylates. 28 Given the lack of knowledge regarding whether oral gavage vs. diet give rise to similar or dissimilar pharmacodynamic and pharmacokinetic profiles, this must remain a consideration when comparing dietary intervention studies.
In terms of signaling mechanisms, a number of mediators may be involved which warrant future study. For example, Seymour et al. reported that the antihypertensive and antihypertrophic actions of grape may be related to enhanced peroxisome proliferator-activated receptor α (PPARα) and PPARγ activity. 29 Ligands of both PPARα and PPARγ block hypertrophy in genetically hypertensive rats. 30, 31 We also showed that activation of these PPAR isoforms is associated with blood pressure lowering and suppression of hypertrophy in the spontaneously hypertensive heart failure rat. 32 Moreover, in SHR vasculature, PPARα and PPARγ are upregulated, 33 and ligand activation of these PPAR isoforms corrects structural abnormalities and endothelial dysfunction in a variety of hypertensive rat models. 34, 35 Another potential mediator is nitric oxide (NO). In addition to its actions as a vasodilator, the potent anti-hypertrophic effect of NO in myocytes is wellestablished. 36 Since a variety of grape-derived products such as grape juice, 37 grape seed, 38 and skin 39 extracts act through enhanced endothelial NO synthase (eNOS) expression and/ or activity, it is plausible that the effects we observed in SHR are mediated by improved NO signaling. However, our data indicate that eNOS gene expression was similar between WKY and SHR mesenteric arteries, and unaffected in either strain by grape powder treatment (see Supplementary Data online). This suggests that improved endothelium-dependent vasodilation by grape powder treatment might be conferred by augmentation of eNOS activity rather than expression. Moreover, in contrast to previous reports on resveratrol by us 10 and others, 40 grape powder treatment failed to reduce oxidative stress in SHR (lipid peroxidation -TBARS concentration in blood serum (nmol/ml); untreated SHR: 14.79 ± 2.72 vs. grape-treated SHR: 10.71 ± 0.55; P = not significant). Thus, any effects of grape treatment on NO signaling are probably largely independent of (i) modulation of eNOS gene expression per se, and (ii) suppression of oxidative stress and subsequent eNOS uncoupling as previously reported for resveratrol. 40 Other mechanisms of enhancing eNOS activity therefore warrant further investigation.
In conclusion, we determined that whole grape consumption reduced blood pressure, improved vascular function and compliance, and attenuated cardiac hypertrophy in the SHR. These findings suggest that regular consumption of grapes might help to maintain healthy blood pressure. Moreover, therapeutic approaches predicated on purified and/or combined formulations of specific grape components (not limited to resveratrol) might be developed as pharmaceutical approaches for more efficacious treatment or prevention of hypertension.
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